$AMN
AMN HEALTHCARE SERVICES INC Stock $amn

$amn Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000114275024000016 Filed on February 22, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$820.9M	$818.3M	$3.789B
YoY Change	-27.11%	-27.3%	-27.73%
Cost Of Revenue	$563.4M	$557.3M	$2.540B
YoY Change	-25.62%	-25.72%	-27.98%
Gross Profit	$257.5M	$260.9M	$1.250B
YoY Change	-30.19%	-30.46%	-27.21%
Gross Profit Margin	31.37%	31.89%	32.98%
Selling, General & Admin	$174.8M	$185.5M	$756.2M
YoY Change	-14.96%	-15.37%	-19.26%
% of Gross Profit	67.9%	71.07%	60.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$44.52M	$41.32M	$154.9M
YoY Change	14.63%	8.66%	12.98%
% of Gross Profit	17.29%	15.83%	12.4%
Operating Expenses	$217.6M	$226.8M	$911.2M
YoY Change	-10.53%	-11.41%	-14.81%
Operating Profit	$39.95M	$34.17M	$338.4M
YoY Change	-68.21%	-71.35%	-47.7%
Interest Expense	$16.63M	-$20.17M	-$54.14M
YoY Change	62.08%	71.35%	-234.02%
% of Operating Profit	41.63%	-59.01%	-16.0%
Other Income/Expense, Net
YoY Change
Pretax Income	$23.32M	$14.01M	$284.3M
YoY Change	-79.8%	-86.97%	-53.14%
Income Tax	$5.989M	$1.516M	$73.61M
% Of Pretax Income	25.69%	10.82%	25.89%
Net Earnings	$17.33M	$12.49M	$210.7M
YoY Change	-79.4%	-84.73%	-52.56%
Net Earnings / Revenue	2.11%	1.53%	5.56%
Basic Earnings Per Share	$0.45		$5.38
Diluted Earnings Per Share	$0.45	$0.33	$5.36
COMMON SHARES
Basic Shares Outstanding	37.89M shares	37.79M shares	39.17M shares
Diluted Shares Outstanding	38.20M shares		39.34M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$50.56M	$32.94M	$32.94M
YoY Change	77.3%	-48.96%	-48.96%
Cash & Equivalents	$50.56M	$32.94M	$32.94M
Short-Term Investments
Other Short-Term Assets	$38.74M	$67.56M	$67.56M
YoY Change	-24.85%	2.3%	-10.95%
Inventory
Prepaid Expenses	$25.28M	$21.89M
Receivables	$578.6M	$741.2M	$741.2M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$790.7M	$841.7M	$841.7M
YoY Change	-26.17%	-23.04%	-23.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$194.5M	$191.4M	$191.4M
YoY Change	25.28%	28.21%	15.61%
Goodwill	$1.115B	$1.112B
YoY Change	19.18%	18.84%
Intangibles	$449.2M	$474.1M
YoY Change	-1.15%	-0.57%
Long-Term Investments
YoY Change
Other Assets	$252.4M	$305.6M	$305.6M
YoY Change	27.91%	96.24%	40.87%
Total Long-Term Assets	$2.083B	$2.083B	$2.083B
YoY Change	15.07%	16.05%	16.05%
TOTAL ASSETS
Total Short-Term Assets	$790.7M	$841.7M	$841.7M
Total Long-Term Assets	$2.083B	$2.083B	$2.083B
Total Assets	$2.874B	$2.924B	$2.924B
YoY Change	-0.26%	1.25%	1.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$316.0M	$343.8M	$343.8M
YoY Change	-33.3%	-27.83%	340.51%
Accrued Expenses	$86.77M	$278.5M	$278.5M
YoY Change	5.38%	276.99%	-32.92%
Deferred Revenue	$11.68M	$11.30M
YoY Change	-15.82%	-4.41%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$623.9M	$656.1M	$656.1M
YoY Change	-22.36%	-23.52%	-23.52%
LONG-TERM LIABILITIES
Long-Term Debt	$1.270B	$1.305B	$1.305B
YoY Change	29.09%	54.67%	54.67%
Other Long-Term Liabilities	$110.0M	$109.0M	$109.0M
YoY Change	-9.63%	-2.0%	-9.61%
Total Long-Term Liabilities	$110.0M	$1.414B	$1.414B
YoY Change	-9.63%	1171.21%	46.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$623.9M	$656.1M	$656.1M
Total Long-Term Liabilities	$110.0M	$1.414B	$1.414B
Total Liabilities	$2.019B	$2.093B	$2.093B
YoY Change	4.89%	13.47%	13.47%
SHAREHOLDERS EQUITY
Retained Earnings	$1.469B	$1.452B
YoY Change	10.86%	16.98%
Common Stock	$505.0K	$504.0K
YoY Change	0.6%	0.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$854.2M	$831.3M	$831.3M
YoY Change
Total Liabilities & Shareholders Equity	$2.874B	$2.924B	$2.924B
YoY Change	-0.26%	1.25%	1.25%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$17.33M	$12.49M	$210.7M
YoY Change	-79.4%	-84.73%	-52.56%
Depreciation, Depletion And Amortization	$44.52M	$41.32M	$154.9M
YoY Change	14.63%	8.66%	12.98%
Cash From Operating Activities	$81.39M	-$41.13M	$372.2M
YoY Change	87.38%	-135.67%	-43.07%
INVESTING ACTIVITIES
Capital Expenditures	$18.15M	$31.59M	$103.7M
YoY Change	3.76%	28.39%	36.73%
Acquisitions			$292.2M
YoY Change			319.97%
Other Investing Activities	-$3.254M	-$292.2M	-$307.1M
YoY Change	-78.23%	-15016.08%	242.03%
Cash From Investing Activities	-$21.40M	-$323.7M	-$412.5M
YoY Change	-34.02%	1329.55%	141.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$38.97M	363.5M	$10.73M
YoY Change	-12.34%	-306.15%	-101.81%
NET CHANGE
Cash From Operating Activities	$81.39M	-41.13M	$372.2M
Cash From Investing Activities	-$21.40M	-323.7M	-$412.5M
Cash From Financing Activities	-$38.97M	363.5M	$10.73M
Net Change In Cash	$21.01M	-1.299M	-$29.60M
YoY Change	-162.81%	-98.45%	-72.81%
FREE CASH FLOW
Cash From Operating Activities	$81.39M	-$41.13M	$372.2M
Capital Expenditures	$18.15M	$31.59M	$103.7M
Free Cash Flow	$63.24M	-$72.72M	$268.5M
YoY Change	143.73%	-180.16%	-53.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Interest Expense InterestExpense	54140000	usd
CY2022	us-gaap	Interest Expense InterestExpense	40398000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32935000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64524000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	22056000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	37225000	usd
CY2023Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	68845000	usd
CY2022Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	61218000	usd
CY2023Q4	amn	Cash Cash Equivalents And Restricted Cash Cash Equivalents And Investments CashCashEquivalentsAndRestrictedCashCashEquivalentsAndInvestments	123836000	usd
CY2022Q4	amn	Cash Cash Equivalents And Restricted Cash Cash Equivalents And Investments CashCashEquivalentsAndRestrictedCashCashEquivalentsAndInvestments	162967000	usd
CY2023Q4	us-gaap	Restricted Investments RestrictedInvestments	15563000	usd
CY2022Q4	us-gaap	Restricted Investments RestrictedInvestments	25095000	usd
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	279000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	360000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.38
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.96
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.36
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.90
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.81
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39173000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44591000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47685000	shares
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001142750
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-16753
CY2023	dei	Entity Registrant Name EntityRegistrantName	AMN HEALTHCARE SERVICES, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	06-1500476
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2999 Olympus Boulevard
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 500
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75019
CY2023	dei	City Area Code CityAreaCode	866
CY2023	dei	Local Phone Number LocalPhoneNumber	871-8519
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2023	dei	Trading Symbol TradingSymbol	AMN
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	4127626484	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37888539	shares
CY2023	dei	Auditor Name AuditorName	KPMG LLP
CY2023	dei	Auditor Location AuditorLocation	San Diego, California
CY2023	dei	Auditor Firm AuditorFirmId	185
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32935000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64524000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	32233000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	31910000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	623488000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	675650000	usd
CY2023Q4	amn	Accounts Receivable Subcontractor AccountsReceivableSubcontractor	117703000	usd
CY2022Q4	amn	Accounts Receivable Subcontractor AccountsReceivableSubcontractor	268726000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	21889000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	18708000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	45670000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	66037000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	841685000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1093645000	usd
CY2023Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	68845000	usd
CY2022Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	61218000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	285081000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	227617000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	191385000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	149276000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	236796000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	172016000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1111549000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	935364000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	442052000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	361327000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	474134000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	476832000	usd
CY2023Q4	us-gaap	Assets Assets	2924394000	usd
CY2022Q4	us-gaap	Assets Assets	2888351000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	343847000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	476452000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	278536000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	333244000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	33738000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	48237000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	656121000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	857933000	usd
CY2023Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	460000000	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	844688000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	843505000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	23350000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	22713000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	108979000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	120566000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2093138000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1844717000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50423000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37810000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50109000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41879000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	504000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	501000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	506543000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	501674000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12613000	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	8230000	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1127043000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	698598000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1451675000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1240996000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-423000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-939000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	831256000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1043634000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2924394000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2888351000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3789254000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5243242000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3984235000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2539673000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3526558000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2674634000	usd
CY2023	us-gaap	Gross Profit GrossProfit	1249581000	usd
CY2022	us-gaap	Gross Profit GrossProfit	1716684000	usd
CY2021	us-gaap	Gross Profit GrossProfit	1309601000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	756238000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	936576000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	730451000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	154914000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	133007000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	101152000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	911152000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1069583000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	831603000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	647101000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	477998000	usd
CY2021	us-gaap	Interest Expense InterestExpense	34077000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	210679000	usd
CY2023	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	516000	usd
CY2022	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-644000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	516000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-644000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-335000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	211195000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	443406000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	327053000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.38
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.96
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.87
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.36
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.90
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.81
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39173000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44591000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47685000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39341000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44870000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48045000	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	819677000	usd
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2688000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-7232000	usd
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	576767000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-15098000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	30066000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	443406000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1043634000	usd
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	428445000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-13148000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18020000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	211195000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	831256000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	210679000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	444050000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	327388000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	160927000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	137111000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	103697000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-8821000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-5330000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	4067000	usd
CY2023	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	0	usd
CY2022	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	0	usd
CY2021	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	158000	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2430000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2930000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	amn	Accounts Receivable And Sales Credits Credit Loss Expense Reversal AccountsReceivableAndSalesCreditsCreditLossExpenseReversal	23913000	usd
CY2022	amn	Accounts Receivable And Sales Credits Credit Loss Expense Reversal AccountsReceivableAndSalesCreditsCreditLossExpenseReversal	57999000	usd
CY2021	amn	Accounts Receivable And Sales Credits Credit Loss Expense Reversal AccountsReceivableAndSalesCreditsCreditLossExpenseReversal	6263000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12933000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-24615000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-16287000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	18020000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	30066000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	25217000	usd
CY2023	amn	Gain Loss On Deferred Compensation GainLossOnDeferredCompensation	-465000	usd
CY2022	amn	Gain Loss On Deferred Compensation GainLossOnDeferredCompensation	526000	usd
CY2021	amn	Gain Loss On Deferred Compensation GainLossOnDeferredCompensation	-20000	usd
CY2023	amn	Gain Loss On Disposal Or Impairment Of Long Lived Assets GainLossOnDisposalOrImpairmentOfLongLivedAssets	-8053000	usd
CY2022	amn	Gain Loss On Disposal Or Impairment Of Long Lived Assets GainLossOnDisposalOrImpairmentOfLongLivedAssets	-1560000	usd
CY2021	amn	Gain Loss On Disposal Or Impairment Of Long Lived Assets GainLossOnDisposalOrImpairmentOfLongLivedAssets	-2707000	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	-302000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-749000	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	52000	usd
CY2023	amn	Lessee Operating Lease Noncash Expense LesseeOperatingLeaseNoncashExpense	1619000	usd
CY2022	amn	Lessee Operating Lease Noncash Expense LesseeOperatingLeaseNoncashExpense	5497000	usd
CY2021	amn	Lessee Operating Lease Noncash Expense LesseeOperatingLeaseNoncashExpense	3806000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-70033000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-57921000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	419533000	usd
CY2023	amn	Increase Decreasein Accounts Receivablessubcontractor IncreaseDecreaseinAccountsReceivablessubcontractor	-151023000	usd
CY2022	amn	Increase Decreasein Accounts Receivablessubcontractor IncreaseDecreaseinAccountsReceivablessubcontractor	29007000	usd
CY2021	amn	Increase Decreasein Accounts Receivablessubcontractor IncreaseDecreaseinAccountsReceivablessubcontractor	165734000	usd
CY2023	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-3793000	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	8875000	usd
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-6591000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1542000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-53806000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	58788000	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-4197000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-17775000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	21999000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	3177000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-210000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-3262000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-183517000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	48782000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	256118000	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-80135000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-10506000	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	129235000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-10248000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-126566000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	122685000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-558000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-4098000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	4320000	usd
CY2023	us-gaap	Increase Decrease In Restricted Cash And Investments For Operating Activities IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities	0	usd
CY2022	us-gaap	Increase Decrease In Restricted Cash And Investments For Operating Activities IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities	0	usd
CY2021	us-gaap	Increase Decrease In Restricted Cash And Investments For Operating Activities IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities	-349000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	372165000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	653733000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	305356000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	103687000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	75831000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	53573000	usd
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	13152000	usd
CY2021	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	60719000	usd
CY2023	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	9894000	usd
CY2022	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	14384000	usd
CY2021	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	57660000	usd
CY2023	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	0	usd
CY2022	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	0	usd
CY2021	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	500000	usd
CY2023	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	77000	usd
CY2022	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	68000	usd
CY2021	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	78000	usd
CY2023	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	24902000	usd
CY2022	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	21518000	usd
CY2021	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	7565000	usd
CY2023	us-gaap	Payments For Leasing Costs PaymentsForLeasingCosts	0	usd
CY2022	us-gaap	Payments For Leasing Costs PaymentsForLeasingCosts	0	usd
CY2021	us-gaap	Payments For Leasing Costs PaymentsForLeasingCosts	1429000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	292175000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	69570000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	41264000	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1700000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	5091000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	90000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-412493000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-170710000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-107402000	usd
CY2023	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	usd
CY2022	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	usd
CY2021	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	21875000	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	355000000	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	70000000	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	815000000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	70000000	usd
CY2023	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	300000	usd
CY2022	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	0	usd
CY2021	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	0	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	424744000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	576767000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2688000	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3579000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	7500000	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	3100000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	13148000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	15098000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	7232000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10729000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-591865000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-34895000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-335000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-29599000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-108842000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	162724000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	83990000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	108273000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	137872000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	246714000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	9311000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	13337000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	39865000	usd
CY2023	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	1229000	usd
CY2022	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	703000	usd
CY2021	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	349000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	48101000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	37518000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	38085000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	78256000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	213807000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	106379000	usd
CY2023	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	48941000	usd
CY2022	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	2604000	usd
CY2021	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	1906000	usd
CY2023	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Goodwill SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill	175770000	usd
CY2022	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Goodwill SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill	42990000	usd
CY2021	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Goodwill SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill	27193000	usd
CY2023	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Intangible Assets SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets	92000000	usd
CY2022	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Intangible Assets SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets	40200000	usd
CY2021	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Intangible Assets SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets	12440000	usd
CY2023	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	24536000	usd
CY2022	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	8224000	usd
CY2021	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	275000	usd
CY2023	amn	Noncash Or Part Noncash Acquisition Earn Out Liability NoncashOrPartNoncashAcquisitionEarnOutLiability	0	usd
CY2022	amn	Noncash Or Part Noncash Acquisition Earn Out Liability NoncashOrPartNoncashAcquisitionEarnOutLiability	8000000	usd
CY2021	amn	Noncash Or Part Noncash Acquisition Earn Out Liability NoncashOrPartNoncashAcquisitionEarnOutLiability	0	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	292175000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	69570000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	41264000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	8130000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5643000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3719000	usd
CY2023	amn	Excise Tax Payable Share Repurchase ExciseTaxPayableShareRepurchase	3701000	usd
CY2022	amn	Excise Tax Payable Share Repurchase ExciseTaxPayableShareRepurchase	0	usd
CY2021	amn	Excise Tax Payable Share Repurchase ExciseTaxPayableShareRepurchase	0	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	36560000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5680000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2672000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to goodwill and indefinite-lived intangible assets, professional liability reserve, contingent liabilities such as legal accruals, and income taxes. The Company bases these estimates on the information that is currently available and on various other assumptions that it believes are reasonable under the circumstances. Actual results could differ from those estimates under different assumptions or conditions.</span></div>
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	108273000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	137872000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	31910000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6838000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5544000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	27622000	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	5221000	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2550000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	32233000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	31910000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of Credit Risk<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div>The majority of the Company’s business activity is with hospitals located throughout the United States. Credit is extended based on the evaluation of each entity’s financial condition. The Company’s cash and cash equivalents and restricted cash, cash equivalents and investments accounts are financial instruments that are exposed to concentration of credit risk. The Company maintains most of its cash, cash equivalents and investment balances with high-credit quality and federally insured institutions. However, cash equivalents and restricted cash equivalents and investment balances may be invested in non-federally insured money market funds, commercial paper and corporate bonds.
CY2023Q4	amn	Cash Cash Equivalents And Restricted Cash Cash Equivalents And Investments CashCashEquivalentsAndRestrictedCashCashEquivalentsAndInvestments	123836000	usd
CY2022Q4	amn	Cash Cash Equivalents And Restricted Cash Cash Equivalents And Investments CashCashEquivalentsAndRestrictedCashCashEquivalentsAndInvestments	162967000	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	88000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	33000	shares
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	210679000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	210679000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	444050000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	444050000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	327388000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	327388000	usd
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.87
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	168000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39341000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44870000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48045000	shares
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	154914000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	133007000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	101152000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	6013000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	4104000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	2545000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	18020000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	30066000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	25217000	usd
CY2023	us-gaap	Interest Expense InterestExpense	54140000	usd
CY2022	us-gaap	Interest Expense InterestExpense	40398000	usd
CY2021	us-gaap	Interest Expense InterestExpense	34077000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	284289000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	606703000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	443921000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3789254000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5243242000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3984235000	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Reclassifications<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To conform to the current year presentation, certain reclassifications have been made to prior year balances in the consolidated balance sheets and accompanying </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0da3f75c0ab24b92939c851f9dd813ff_115" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note (</a><a href="#i0da3f75c0ab24b92939c851f9dd813ff_115" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">6</a><a href="#i0da3f75c0ab24b92939c851f9dd813ff_115" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">)</a></span>, “Balance Sheet Details.”
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	5635000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	9928000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	15563000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	916186000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	442052000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	474134000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	838159000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	361327000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	476832000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	89756000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	83078000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	92766000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	75637000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	67111000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	56070000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	35891000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	146659000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	474134000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	892341000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	935364000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1111549000	usd
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	214939000	usd
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	214939000	usd
CY2023Q4	amn	Lessee Operating Lease Renewal Options LesseeOperatingLeaseRenewalOptions	1	option
CY2023Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P10Y
CY2023	amn	Lessee Operating Lease Termination Period LesseeOperatingLeaseTerminationPeriod	P2Y
CY2021	amn	Number Of Phases Of Lease Termination Agreement NumberOfPhasesOfLeaseTerminationAgreement	2	phase
CY2021	amn	Payments Of Lease Termination Fee PaymentsOfLeaseTerminationFee	17000000	usd
CY2021	amn	Operating Lease Right Of Use Asset Increase Decrease From Modification OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification	-27340000	usd
CY2021	amn	Operating Lease Liability Increase Decrease From Modification OperatingLeaseLiabilityIncreaseDecreaseFromModification	-27340000	usd
CY2021Q4	amn	Lessee Operating Lease Liability To Be Paid Premodification LesseeOperatingLeaseLiabilityToBePaidPremodification	62487000	usd
CY2021Q4	amn	Lessee Operating Lease Liability To Be Paid Postmodification LesseeOperatingLeaseLiabilityToBePaidPostmodification	9564000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	9610000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	16439000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	23495000	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3738000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	5787000	usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	6056000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	2789000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	3129000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	2485000	usd
CY2023	us-gaap	Lease Cost LeaseCost	16137000	usd
CY2022	us-gaap	Lease Cost LeaseCost	25355000	usd
CY2021	us-gaap	Lease Cost LeaseCost	32036000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	10584000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	8150000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	6437000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	6494000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	6665000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	16765000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	55095000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9499000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	45596000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2023Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.053
CY2022Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.031
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	22056000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	37225000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	5350000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	8875000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	18264000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	19937000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	45670000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	66037000	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	71815000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	51408000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	388812000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	323418000	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	15839000	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2067000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	476466000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	376893000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	285081000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	227617000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	191385000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	149276000	usd
CY2023Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	162780000	usd
CY2022Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	117139000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	34543000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16266000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	39473000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	38611000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	236796000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	172016000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	54128000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	78057000	usd
CY2023Q4	amn	Accounts Payable To Subcontractor AccountsPayableToSubcontractor	122983000	usd
CY2022Q4	amn	Accounts Payable To Subcontractor AccountsPayableToSubcontractor	295259000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	82257000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	73885000	usd
CY2023Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	69837000	usd
CY2022Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	14638000	usd
CY2023Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	7761000	usd
CY2022Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	7756000	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	6881000	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	6857000	usd
CY2023Q4	amn	Accounts Payable And Accrued Expenses Excluding Accrued Compensation And Benefits Current AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent	343847000	usd
CY2022Q4	amn	Accounts Payable And Accrued Expenses Excluding Accrued Compensation And Benefits Current AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent	476452000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	53633000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	63857000	usd
CY2023Q4	amn	Accrued Bonuses And Commissions AccruedBonusesAndCommissions	31236000	usd
CY2022Q4	amn	Accrued Bonuses And Commissions AccruedBonusesAndCommissions	96760000	usd
CY2023Q4	amn	Share Based Payment Arrangement Employee Stock Purchase Program Contribution Current ShareBasedPaymentArrangementEmployeeStockPurchaseProgramContributionCurrent	950000	usd
CY2022Q4	amn	Share Based Payment Arrangement Employee Stock Purchase Program Contribution Current ShareBasedPaymentArrangementEmployeeStockPurchaseProgramContributionCurrent	0	usd
CY2023Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	12130000	usd
CY2022Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	12113000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	165574000	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	128465000	usd
CY2023Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	15013000	usd
CY2022Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	32049000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	278536000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	333244000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	11303000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	11825000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	5070000	usd
CY2023Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	8707000	usd
CY2022Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	21466000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7993000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	8090000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	5735000	usd
CY2022Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	1786000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	33738000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	48237000	usd
CY2023Q4	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	21169000	usd
CY2022Q4	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	23841000	usd
CY2023Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	36891000	usd
CY2022Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	36214000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	37603000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9360000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	13316000	usd
CY2022Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	51151000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	108979000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	120566000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	65877000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	145217000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	98795000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	20666000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	42051000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	34025000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	86543000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	187268000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	132820000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-10203000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-20173000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-12992000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2730000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4442000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3295000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12933000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-24615000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-16287000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	73610000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	162653000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	116533000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	59701000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	127390000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	93223000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	14170000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	29711000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	23990000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	3010000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	0	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	0	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-944000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-2383000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1460000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	1957000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	3245000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-680000	usd
CY2023	amn	Effective Income Tax Rate Reconciliation Company Owned Life Insurance Amount EffectiveIncomeTaxRateReconciliationCompanyOwnedLifeInsuranceAmount	-4428000	usd
CY2022	amn	Effective Income Tax Rate Reconciliation Company Owned Life Insurance Amount EffectiveIncomeTaxRateReconciliationCompanyOwnedLifeInsuranceAmount	4094000	usd
CY2021	amn	Effective Income Tax Rate Reconciliation Company Owned Life Insurance Amount EffectiveIncomeTaxRateReconciliationCompanyOwnedLifeInsuranceAmount	-1968000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	3172000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	2741000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	551000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	3316000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	3337000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	3979000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	73610000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	162653000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	116533000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5461000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7556000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	41976000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	32962000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	2585000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	22437000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	11426000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	14452000	usd
CY2023Q4	amn	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	11296000	usd
CY2022Q4	amn	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	4532000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4809000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5803000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves	813000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves	10857000	usd
CY2023Q4	amn	Deferred Tax Assets Workers Compensation Insurance DeferredTaxAssetsWorkersCompensationInsurance	5997000	usd
CY2022Q4	amn	Deferred Tax Assets Workers Compensation Insurance DeferredTaxAssetsWorkersCompensationInsurance	6661000	usd
CY2023Q4	amn	Deferred Tax Assets Professional Services Expenses DeferredTaxAssetsProfessionalServicesExpenses	16242000	usd
CY2022Q4	amn	Deferred Tax Assets Professional Services Expenses DeferredTaxAssetsProfessionalServicesExpenses	419000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	9161000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	9074000	usd
CY2023Q4	amn	Deferred Tax Assets Sales Credits DeferredTaxAssetsSalesCredits	6896000	usd
CY2022Q4	amn	Deferred Tax Assets Sales Credits DeferredTaxAssetsSalesCredits	6233000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1516000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3749000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	118178000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	124735000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	111590000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	114967000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	14947000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	21739000	usd
CY2023Q4	amn	Deferred Tax Liabilities Operating Lease Right Of Use Assets DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets	8539000	usd
CY2022Q4	amn	Deferred Tax Liabilities Operating Lease Right Of Use Assets DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets	4228000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	6452000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	6514000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	141528000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	147448000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	23350000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	22713000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6980000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4067000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4916000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1873000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1464000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	504000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	491000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1966000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	301000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	655000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	517000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1052000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8689000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6980000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4067000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	9138000	usd
CY2023Q4	amn	Unrecognized Tax Benefits That Would Impact Effective Tax Rate Temporary Differences UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRateTemporaryDifferences	1495000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	1942000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	1390000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	564000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	552000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	826000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	34000	usd
CY2022Q4	amn	Deferred Payroll Taxes Cares Act DeferredPayrollTaxesCARESAct	48452000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1310000000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	850000000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	5312000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	6495000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	1304688000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	843505000	usd
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	5673000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	31409000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	13157000	usd
CY2023Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	162780000	usd
CY2022Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	117139000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	150000000	usd
	amn	Stock Repurchase Program Authorized Cumulative Amount StockRepurchaseProgramAuthorizedCumulativeAmount	700000000	usd
CY2023Q1	amn	Stock Repurchase Program Authorized Cumulative Amount StockRepurchaseProgramAuthorizedCumulativeAmount	500000000	usd
CY2023Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	1350000000	usd
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	226658000	usd
CY2023	amn	Treasury Stock Shares Acquired Excluding Accelerated Share Repurchases TreasuryStockSharesAcquiredExcludingAcceleratedShareRepurchases	2362000	shares
CY2023	amn	Treasury Stock Shares Acquired Average Cost Per Share Excluding Accelerated Share Repurchases TreasuryStockSharesAcquiredAverageCostPerShareExcludingAcceleratedShareRepurchases	95.13
CY2023	amn	Treasury Stock Value Acquired Cost Method Excluding Accelerated Share Repurchases TreasuryStockValueAcquiredCostMethodExcludingAcceleratedShareRepurchases	224744000	usd
CY2023	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	4383000	shares
CY2022	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	5644000	shares
CY2021	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	25000	shares
CY2023	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	96.90
CY2022	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	102.16
CY2021	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	108.97
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	424744000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	576767000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2688000	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	717000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	58.88
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	280000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	56.05
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	158000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	65.69
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	755000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	78.13
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	94.79
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	349000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	89.76
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	87000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	104.14
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	601000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	405000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	72.43
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	75000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	82.13
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	665000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	101.01
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18020000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	30066000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25217000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	4685000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	7817000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	6556000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	13335000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	22249000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	18661000	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001142750-24-000016-index-headers.html	Edgar Link	pending
0001142750-24-000016-index.html	Edgar Link	pending
0001142750-24-000016.txt	Edgar Link	pending
0001142750-24-000016-xbrl.zip	Edgar Link	pending
amn-20231231.htm	Edgar Link	pending
amn-20231231.xsd	Edgar Link	pending
amn-20231231_g1.jpg	Edgar Link	pending
amn-20231231_g2.jpg	Edgar Link	pending
amn-20231231_def.xml	Edgar Link	unprocessable
amn-ex1040x20231231x10k.htm	Edgar Link	pending
amn-ex1041x20231231x10k.htm	Edgar Link	pending
amn-ex1042x20231231x10k.htm	Edgar Link	pending
amn-ex1043x20231231x10k.htm	Edgar Link	pending
amn-ex1044x20231231x10k.htm	Edgar Link	pending
amn-ex1045x20231231x10k.htm	Edgar Link	pending
amn-ex1046x20231231x10k.htm	Edgar Link	pending
amn-ex1047x20231231x10k.htm	Edgar Link	pending
amn-ex1048x20231231x10k.htm	Edgar Link	pending
amn-ex211x20231231x10k.htm	Edgar Link	pending
amn-ex231x20231231x10k.htm	Edgar Link	pending
amn-ex311x20231231x10k.htm	Edgar Link	pending
amn-ex312x20231231x10k.htm	Edgar Link	pending
amn-ex321x20231231x10k.htm	Edgar Link	pending
amn-ex322x20231231x10k.htm	Edgar Link	pending
amn-ex971x20231231x10k.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
image_0b.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
amn-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
amn-20231231_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
amn-20231231_cal.xml	Edgar Link	unprocessable
amn-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMN
AMN HEALTHCARE SERVICES INC Stock $amn

2024 Q1 Form 10-K Financial Statement

#000114275024000016 Filed on February 22, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMN AMN HEALTHCARE SERVICES INC Stock $amn

2024 Q1 Form 10-K Financial Statement

#000114275024000016 Filed on February 22, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMN
AMN HEALTHCARE SERVICES INC Stock $amn